PANTHERx® Specialty Pharmacy’s Chairman & CEO, Dr. Gordon J. Vanscoy, and PANTHERx®’s Manager of Clinical Programs, Dr. Christa Eans, will lead a Live CE Webinar...

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, and RxCrossroads™ by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program...

August 22nd PANTHERx® Specialty Pharmacy was recognized by the Pittsburgh Business Times as the #1 Fastest Growing Company in Pittsburgh for 2018. This is the...

PANTHERx® Specialty Pharmacy’s Chairman & CEO, Dr. Gordon J. Vanscoy presented Matthew Misorski, Pharm.D., with a certificate in recognition of his completion of the PANTHERx®...

The National Association of Specialty Pharmacy (NASP) recently announced the launch of their new Student Association of Specialty Pharmacy (SASP) via a segment on the...

PANTHERx® Specialty Pharmacy announced today that it has entered into a partnership with The Health Plan as a provider of specialty pharmacy medications across multiple...

PANTHERx® Specialty Pharmacy announced today that it has expanded its preferred partnership with Highmark to include Crysvita™ (burosumab-twza). Crysvita™ (burosumab-twza) is the first FDA-approved therapy...

Gene therapy isn’t on the horizon anymore; it’s here.  Precision medicine demands a level of personalization that few Specialty Pharmacies are equipped to handle.  PANTHERx®’s...

PANTHERx® Specialty Pharmacy is pleased to announce that it has received full reaccreditation from URAC, pursuant to Specialty Pharmacy, Version 3.0. This accreditation is a...